Evidence map›Paper›PMID 41737412›Full record

ArticleOpen medicine (Warsaw, Poland)2026

Proteomic alterations in outer membrane vesicles of carbapenem-resistant

JingJing Kang, LinLin Xu, TengFei Xiao

Abstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

JingJing KangDepartment of Clinical Laboratory, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, The First People's Hospital of Yancheng, Yancheng City, Jiangsu Province, China.
LinLin XuDepartment of Clinical Laboratory, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, The First People's Hospital of Yancheng, Yancheng City, Jiangsu Province, China.
TengFei XiaoDepartment of Clinical Laboratory, Yancheng Third People's Hospital, Affiliated Hospital 6 of Nantong University, Yancheng City, Jiangsu Province, China.ORCID https://orcid.org/0000-0002-0659-5530

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Carbapenem-resistant Methods: Three CRKP and three carbapenem-sensitive Results: A total of 1,193 OMV proteins were identified, with CRKP-OMVs containing substantially more unique proteins (140 vs. 5 in CSKP-OMVs) and significantly increased overall protein abundance. Among the 199 differential proteins, 180 were upregulated in CRKP-OMVs. Most differential proteins were localized to the membrane or cytoplasm, and were enriched in enzymatic functions and pathways including β-alanine metabolism, O-antigen nucleotide sugar biosynthesis, Lipopolysaccharide biosynthesis, and β-lactam resistance. Key proteins such as adhE, NDK, treA, and ackA were markedly elevated, while galE and Ter family proteins were uniquely present in CRKP-OMVs, indicating potential roles in resistance and pathogenicity. Conclusions: CRKP-derived OMVs from sepsis patients exhibit distinct protein enrichment patterns associated with membrane functions, metabolic remodeling, and antibiotic resistance. These findings provide insights into CRKP pathogenesis and highlight candidate OMV-associated proteins that may serve as targets for antimicrobial strategies or vaccine development.

Indexed as

antibiotic resistancecarbapenem-resistant Klebsiella pneumoniaedifferential protein analysisouter membrane vesiclessepsis

Identifiers

PMID41737412
PMCPMC12927459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.